These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4018932)

  • 1. Hypercalcemia in 25 OH D3 treated patients receiving a calcium exchange resin.
    Labeeuw M; Cabanne JF
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):316-9. PubMed ID: 4018932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-line haemodiafiltration improves response to calcifediol treatment.
    Pérez-García R; Albalate M; de Sequera P; Alcázar R; Puerta M; Ortega M; Corchete E
    Nefrologia; 2012 Jul; 32(4):459-66. PubMed ID: 22652556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypercalcaemic crises in patients with chronic renal failure caused by ion-exchange resins, antacidotics and other calcium-containing drugs (author's transl)].
    Graben N; Cremer W; Anlauf M; Bock KD
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1903-7. PubMed ID: 598299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypercalcemic crises in patients with chronic kidney failure due to calcium-containing ion-exchangers, antacids and other drugs].
    Graben N; Cremer W; Anlauf M; Bock KD
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1505-8. PubMed ID: 1030032
    [No Abstract]   [Full Text] [Related]  

  • 6. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcaemia from calcium resin.
    Bone JM; Davison AM
    Lancet; 1968 Nov; 2(7578):1137. PubMed ID: 4177178
    [No Abstract]   [Full Text] [Related]  

  • 8. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle).
    Frohnert PP; Johnson WJ; Mueller GJ; Tauxe WN; McCall JT
    J Lab Clin Med; 1968 May; 71(5):840-6. PubMed ID: 5647685
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum osteocalcin and vitamin D in postmenopausal diabetic azotemics.
    Lu KC; Shieh SD; Chyr SH; Lin SH; Li BL; Diang LK; Chen WQ; Lin YF
    Diabetes Res; 1993; 22(3):97-104. PubMed ID: 8076446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcaemia from calcium ion-exchange resin in patients on regular haemodialysis.
    Papadimitriou M; Gingell JC; Chisholm GD
    Lancet; 1968 Nov; 2(7575):948-50. PubMed ID: 4176266
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S; Kratzsch J; Paschke R; Koch CA
    Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cortico-dependent hypercalcemia in 3 patients on chronic hemodialysis].
    Fuss M; Van Herweghem JL; Bergman P; Verbeelen D
    J Urol Nephrol (Paris); 1978; 84(4-5):318-23. PubMed ID: 682232
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.
    Gkonos PJ; London R; Hendler ED
    N Engl J Med; 1984 Dec; 311(26):1683-5. PubMed ID: 6548798
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypercalcaemia from calcium resin in patients with chronic renal failure.
    Sevitt LH; Wrong OM
    Lancet; 1968 Nov; 2(7575):950-1. PubMed ID: 4176267
    [No Abstract]   [Full Text] [Related]  

  • 18. Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy.
    Meric F; Yap P; Bia MJ
    Am J Kidney Dis; 1990 Nov; 16(5):459-64. PubMed ID: 2239937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcaemia from calcium resin.
    Knapp MS; Heath DA
    Lancet; 1968 Nov; 2(7578):1136-7. PubMed ID: 4177177
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypercalcemia due to hypervitaminosis D: report of seven patients.
    Joshi R
    J Trop Pediatr; 2009 Dec; 55(6):396-8. PubMed ID: 19339514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.